-
1
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
Published 2020“…American Society of Hematology…”
Journal article -
2
Outcomes of relapsed/refractory patients with IDH1/2 mutated AML treated with non-targeted therapy: results from the NCRI AML trials
Published 2018“…American Society of Hematology…”
Conference item -
3
Modelling the progression of a preleukemic stage to overt leukemia in children with down syndrome
Published 2018“…American Society of Hematology…”
Conference item -
4
Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations
Published 2018“…American Society of Hematology…”
Journal article -
5
International Consensus Classification of myeloid neoplasms and acute leukemia: Integrating morphological, clinical, and genomic data.
Published 2022“…American Society of Hematology…”
Journal article -
6
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response
Published 2017“…American Society of Hematology…”
Journal article